Chargement en cours...
Safety and Biodistribution Evaluation in Cynomolgus Macaques of rAAV2tYF-PR1.7-hCNGB3, a Recombinant AAV Vector for Treatment of Achromatopsia
Applied Genetic Technologies Corporation (AGTC) is developing rAAV2tYF-PR1.7-hCNGB3, a recombinant adeno-associated viral (rAAV) vector expressing the human CNGB3 gene, for treatment of achromatopsia, an inherited retinal disorder characterized by markedly reduced visual acuity, extreme light sensit...
Enregistré dans:
| Publié dans: | Hum Gene Ther Clin Dev |
|---|---|
| Auteurs principaux: | , , , , , , , , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Mary Ann Liebert, Inc.
2016
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4851175/ https://ncbi.nlm.nih.gov/pubmed/27003753 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/humc.2015.164 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|